Develop and write economic sections of HTA and vaccine submissions
Build and validate cost-effectiveness and budget impact models
Ensure clarity, robustness, and quality of economic evidence
Manage external vendors producing models or analyses
Represent the company in HTA meetings and advisory settings
Contribute to submission strategy and resolve technical challenges
Cross-functional & Global Collaboration
Work closely with UK, global, and external stakeholders
Input into clinical trial design and global model development
Align with pricing, medical, and market access teams
Communicate risks, opportunities, and evidence needs
Evidence Generation
Support studies to address evidence gaps (incl. real-world data)
Contribute to systematic reviews, NMAs, and methodological research
Generate economic evidence across a product's lifecycle
Lifecycle & Strategic Support
Assess pipeline products for HTA risks and opportunities
Support launch planning and market access strategy
Contribute to cross-functional planning and horizon scanning
Capability Building
Maintain expertise in health economics and HTA methods
Support team knowledge development and best practice
Key Skills & Focus
Strong health economic modelling and HTA expertise
Clear, concise scientific communication
Stakeholder collaboration (internal & external)
Strategic thinking across product lifecycle
Qualifications, Skills & Experience Required:
Master's degree in Health Economics or related discipline
Strong experience in some or all of economic modelling, evidence synthesis, outcomes research, HTA dossier preparation and responding to feedback and clarifications from HTA agencies
Knowledge of NICE methods and processes
Understanding of the NHS
Competencies/Skills:
Excellent communication skills (verbal and written as well as presentation skills)
Quantitative and statistical literacy; comfortable working with complex datasets and assumptions; excellent analytical skills
Working collaboratively in a matrix organisation
Strong organisational and prioritisation skills across multiple concurrent projects
Proven ability to lead end‑to‑end HTA projects to tight timelines and high quality
Benefits
The opportunity to be involved in a broad range of therapy areas and a large volume of submission workHigh levels of autonomy and ownership in developing HTA submission dossiers in-houseInvolvement in the end-to-end HTA work, from clinical trial design to post-HTA approvalBeing part of a global organization and collaborate with colleagues around the worldHave the chance to influence global and local decision making that impacts the lives of thousands of peopleA supportive and positive company cultureProfessional development and training opportunitiesYour role at our company is integral to helping the world meet new breakthroughs that affect generations to come, and we're counting on your skills and inventiveness to help make meaningful contributions to global medical advancement.Closing date: 21st June 2026Required Skills:3D Model Making, Clinical Study Design, Clinical Trials, Data Management, Health Economics, Health Outcomes Research, Market Access, Medical Economics, Outcomes Research, Product Lifecycle, Psychotherapy, Researching, Sketch Modelling, Stakeholder Relationship Management, Strategic PlanningPreferred Skills:Current Employees apply HERECurrent Contingent Workers apply HERESearch Firm Representatives Please Read CarefullyHealth insurance
Additional Information
Job Description
Calling all health economists!
We are recruiting for a new Health Economics Manager (Senior Specialist) , based in Moorgate, London. This is an opportunity to join one of the UK's largest and most active HTA & Outcomes Research teams and to help secure national access to innovative medicines and vaccines.
The successful candidate will lead and deliver high-quality health economic analyses to support national access to medicines and vaccines, ensuring strong submissions to UK HTA bodies (e.g. NICE, SMC, JCVI) as part of a cross-functional team.
Merck · - London - London (moorgate Wework), UK